Drug intelligence / Profile preview

Boost

Development stage: Unknown
Lead developer: EO Care
Modality: Small Molecules
Administration: Oral

Overview

Boost is a clinician-designed, hemp-derived cannabinoid wellness product developed by EO Care. It is part of a suite of products (including Vitality, Clarity, Relief, and Rest) specifically formulated for symptom management, with a particular focus on patients undergoing cancer treatment. The product utilizes standardized hemp extracts to address cancer-related symptoms and improve quality of life, with clinical efficacy tracked using PROMIS (Patient-Reported Outcomes Measurement Information System) metrics. As a consumer wellness product, it is marketed directly to patients and employers as a non-pharmaceutical option for managing side effects associated with oncology care.

Brand names: Boost
Other names: EO Care Boost

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Boost.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Boost.

Explore the full profile